Edition:
India

DarioHealth Corp (DRIO.OQ)

DRIO.OQ on NASDAQ Stock Exchange Capital Market

1.93USD
8:00pm IST
Change (% chg)

$0.09 (+4.89%)
Prev Close
$1.84
Open
$1.86
Day's High
$2.14
Day's Low
$1.86
Volume
72,743
Avg. Vol
35,050
52-wk High
$3.64
52-wk Low
$1.32

Select another date:

Mon, Mar 26 2018

BRIEF-DarioHealth Receives U.S. FDA Clearance For iPhone 7, 8 And iPhone X Smart Glucose Meter

* DARIOHEALTH RECEIVES U.S. FDA CLEARANCE FOR IPHONE 7, 8 AND IPHONE X SMART GLUCOSE METER Source text for Eikon: Further company coverage:

BRIEF-DarioHealth Reports Fourth Quarter And Year End 2017 Results

* DARIOHEALTH REPORTS FOURTH QUARTER AND YEAR END 2017 RESULTS

BRIEF-DarioHealth Says Qtrly Reports On Form 10-Q For Quarter Ended March 30, 2017, June 30, 2017 And Sept 30, 2017 Should No Longer Be Relied Upon​

* DARIOHEALTH - QTRLY REPORTS ON FORM 10-Q FOR QUARTER ENDED MARCH 30, 2017, JUNE 30, 2017 AND SEPT 30, 2017 FILED WITH SEC SHOULD NO LONGER BE RELIED UPON​

BRIEF-Dariohealth Launches Sales Of Dario Blood Glucose Monitoring System On Amazon Prime

* DARIOHEALTH LAUNCHES SALES OF DARIO™ BLOOD GLUCOSE MONITORING SYSTEM ON AMAZON PRIME

BRIEF-DarioHealth Wins Key Contract In Clinical Study

* DARIOHEALTH WINS KEY CONTRACT ENSURING ITS PLATFORM TO BE UTILIZED IN CLINICAL STUDY

BRIEF-Dariohealth - ‍ Received Therapeutic Goods Administration Mark For Its Lightning-Enabled Version Of Dario Blood Glucose Monitoring System

* DARIOHEALTH - ‍ RECEIVED THERAPEUTIC GOODS ADMINISTRATION MARK FOR ITS LIGHTNING-ENABLED VERSION OF DARIO BLOOD GLUCOSE MONITORING SYSTEM IN AUSTRALIA​

BRIEF-Dariohealth Corp Q3 revenue $1.375 million

* Qtrly basic and diluted loss per share $0.30‍​ Source text for Eikon: Further company coverage:

Select another date: